WiseBuzz announced on the 18th that it is establishing a dedicated team for US Direct‑to‑Consumer (DTC) advertising. The move aims to assist Korean pharmaceutical, biotech and healthcare companies in entering the US market.
DTC advertising allows companies to promote prescription drugs, medical devices and other health products directly to consumers. The United States is one of the few markets where prescription‑drug advertising to the general public is permitted, and several Korean firms already use DTC campaigns after expanding into the US.
WiseBuzz plans to run the DTC business as a core service, providing expertise and resources for Korean firms seeking to build brand awareness among US consumers.
Analyse30 août 2026•1 min de lecture
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.
Compilé par l'équipe PharmaCountry · Source : KPA News
Évaluations
(0)
(0)
(0)
(0)
(0)
Plus d'articles
Voir tous les articlesRecherches & Rapports
Global Finished Dosage Manufacturing Landscape 2026
5 oct. 2026
Actualités réglementairesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept. 2026
Laissez votre note